Atlantic International Corp. (ATLN)
USD 4.99
(2.46%)
USD 4.99
(2.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.82 Million USD | -5.4% |
| 2022 | 4.04 Million USD | 58.24% |
| 2021 | 2.55 Million USD | -43.76% |
| 2020 | 4.54 Million USD | 22.35% |
| 2019 | 3.71 Million USD | 137.28% |
| 2018 | 1.56 Million USD | -44.72% |
| 2017 | 2.83 Million USD | 39.87% |
| 2016 | 2.02 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.77 Million USD | -1.35% |
| 2024 Q2 | 111.18 Million USD | 2843.98% |
| 2023 Q3 | 3.75 Million USD | -0.18% |
| 2023 FY | 3.82 Million USD | -5.4% |
| 2023 Q1 | 4.24 Million USD | 4.84% |
| 2023 Q4 | 3.82 Million USD | 1.96% |
| 2023 Q2 | 3.76 Million USD | -11.35% |
| 2022 Q2 | 3.72 Million USD | -4.24% |
| 2022 FY | 4.04 Million USD | 58.24% |
| 2022 Q4 | 4.04 Million USD | 5.47% |
| 2022 Q3 | 3.83 Million USD | 3.07% |
| 2022 Q1 | 3.88 Million USD | 52.0% |
| 2021 Q3 | 2.67 Million USD | 0.0% |
| 2021 FY | 2.55 Million USD | -43.76% |
| 2021 Q4 | 2.55 Million USD | -4.52% |
| 2020 FY | 4.54 Million USD | 22.35% |
| 2019 FY | 3.71 Million USD | 137.28% |
| 2018 FY | 1.56 Million USD | -44.72% |
| 2017 FY | 2.83 Million USD | 39.87% |
| 2016 FY | 2.02 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -6.115% |
| Arrayit Corporation | 7.49 Million USD | 48.929% |
| Biocept, Inc. | 22.01 Million USD | 82.607% |
| Bioqual, Inc. | 18.93 Million USD | 79.783% |
| CardioGenics Holdings Inc | 1.79 Million USD | -113.303% |
| DermTech, Inc. | 64.75 Million USD | 94.088% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 99.479% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 69.089% |
| iMD Companies, Inc. | 1.67 Million USD | -128.681% |
| IDenta Corp. | 1.01 Million USD | -277.89% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 86.403% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -1185.0% |
| InVitro International | 78.99 Thousand USD | -4746.965% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 80.594% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -2861.104% |
| Medical Imaging Corp. | 9.51 Million USD | 59.771% |
| NovelStem International Corp. | 4.2 Million USD | 8.974% |
| Optigenex Inc. | 9.57 Million USD | 59.996% |
| PharmChem, Inc. | 558.64 Thousand USD | -585.338% |
| Proteome Sciences plc | 18.48 Million USD | 79.293% |
| Response Genetics, Inc | 15.86 Million USD | 75.871% |
| Rennova Health, Inc. | 49.66 Million USD | 92.291% |
| RushNet, Inc. | 6.23 Million USD | 38.634% |
| ScreenPro Security Inc. | 1.6 Million USD | -139.201% |
| Stella Diagnostics Inc. | 18 Million USD | 78.736% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | 53.332% |
| Todos Medical Ltd. | 50.15 Million USD | 92.367% |